Clinical Trials
8 trialsNCT06950385 2026-06-02
SERENTA
Rapamycin Holdings Inc.
Phase 3 Recruiting
NCT05919264 2026-05-28
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Phase 1/2 Recruiting
NCT06614738 2026-05-27
Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)
Hospices Civils de Lyon
Recruiting
NCT06641310 2026-05-19
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
University of Michigan Rogel Cancer Center
Phase NA Recruiting
NCT05223036 2026-05-14
Testing Obeticholic Acid for Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Terminated
NCT05630794 2026-05-13
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT06557733 2026-05-13
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06308445 2026-05-08
RAPA-4-PAF
University Hospital, Toulouse
Phase 2 Not yet recruiting